3M™ Curos™ Disinfecting Port Protectors

3M™ Curos™ Disinfecting Caps

Curos disinfecting caps are alcohol-containing caps that twist onto I.V. access points for disinfection and protection. Consistent use of Curos disinfecting caps on I.V. needleless connectors is associated with decreased central line associated bloodstream infections (CLABSIs).

Disinfects in one minute. Protects catheter access points for up to seven days.

Each Curos disinfecting cap contains 70% isopropyl alcohol (IPA). The IPA bathes the surfaces of the access point, disinfects it in one minute and keeps the access site clean and protected for seven days.

The Curos™ brand offers a full circle of disinfection and protection for intraluminal access points including:

  • Needleless Connectors
  • Male Luers
  • Catheter Hubs
  • Tego® Hemodialysis Connector


Curos™ Disinfecting Cap for Needleless Connectors
3M™ Curos™ Stopper Disinfecting Cap
3M™ Curos Tips™ Disinfecting Cap for Male Luers
3M™ Curos™ Disinfecting Cap for Tego® Connectors

Advantages over scrubbing

The traditional standard of care for catheter hub or connector disinfection has been a thorough manual scrub with an alcohol wipe, often referred to as "scrubbing the hub." Curos™ disinfecting caps provide several advantages over the scrub the hub protocol:

  • Curos stopper image
    Save time

    Curos alcohol impregnated caps provide fast passive disinfection, saving nurses valuable time compared to most scrub the hub procedures. In addition, no drying time is required to achieve disinfection.

  • Curos physical barrier
    Provide a physical barrier

    They provide a physical barrier to contamination, between accesses for up to seven days.

  • Curos technique variation
    Remove user technique variation

    Once a Curos cap is twisted into place, it provides consistent disinfection.

  • Curos visual confirmation
    Provide visual confirmation

    Curos caps' bright colour help
    caregivers verify that a port is clean at a glance.



3M™ Curos™ Disinfecting Port Protectors achieved a 99.99% reduction in six microbes commonly associated with CLABSI*

The effectiveness of Curos disinfecting port protectors was tested in vitro against**: Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Candida albicans, Pseudomonas aeruginosa, and Candida glabrata. All test samples exceeded the minimum 4-log reduction after one minute. (3M data on file.)

Disinfecting port protectors
  1. For more information regarding organisms associated with central line–associated bloodstream infections, refer to: Weiner et al. (2016). Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infection Control & Hospital Epidemiology
  2. Data reflects in vitro findings on Curos™ Disinfecting Port Protectors (Data on file)

  • Reducing infection risk

    Three keys to reducing bloodstream infection risk

    As your trusted partner in protecting patients, we share your goal of sustaining zero bloodstream infections. And we want to do everything in our power to help you achieve it.

    We believe there are three keys to reaching this goal: people, standards, and technology. It’s an effort that requires exacting standards of care, a commitment from the care team to methodically adhere to those standards, and technology that adds an additional layer of antimicrobial protection.


Request an online consultation

Our 3M specialists can't wait to get back in the field with our clinical customers, but in the meantime, we can offer online consultations and virtual demonstrations. We're here for you.


3M™ Curos™ Disinfecting Port Protectors videos



References

*For more information regarding organisms associated with central line–associated bloodstream infections, refer to:
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., . . . Fridkin, S. (2013). Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infection Control & Hospital Epidemiology, 34(01), 1-14. doi:10.1086/668770
**Data reflects in vitro findings on Curos™ Disinfecting Port Protectors

  1. Merrill, et. Al, Impact of Universal Disinfectant Cap Implementation on Central Line-Associated Bloodstream Infections. American Journal of Infection Control. December 2014: Volume 40 (12)
  2. Cameron-Watson. Port Protectors in Clinical Practice: An Audit. British Journal of Nursing: (IV Therapy Supplement). 2016: Vol 25 (8)
  3. Forcing the Function: Implementation and Evaluation of an IV Port Protector to Decrease CLABSI. Legacy Health, Portland, Oregon: Mary Davis, BSN, RN, CCRN